Magnera
Magnera reported revenue of $3.2 billion in fiscal 2025. Its operating margin was 0.2%, about the same as 0.2% a year earlier. Free cash flow was $36 million.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What Magnera does
Magnera makes specialty materials, such as nonwoven fabrics and films, from natural and synthetic raw ingredients. Its products go into consumer goods like wipes, healthcare items, adult incontinence products, apparel, baby and feminine care products, air filters, and food and beverage items such as tea bags and coffee filters. It also provides technical solutions for infrastructure markets. Its customers range from global and national brands to private-label makers and smaller regional businesses.
The company has two reporting segments. Americas is the larger, at about 57% of net sales, with plants in the United States, Brazil, Mexico, Canada and Colombia. Rest of World is about 43% of net sales, with plants in Europe, China and the Philippines. It sells through its own direct sales force and says competition rests on service, innovation, quality and price.
Magnera was formed on November 4, 2024, when Treasure Holdco, a subsidiary of Berry Global, merged with Glatfelter, which took the Magnera name. Treasure's shareholders received 90% of the combined company.
Its biggest risks, as it describes them
- Global economic conditions, inflation and supply chain disruptions.
- Higher raw material and energy costs, or shortages of them.
- Not competing successfully, and customers that may stop buying its products.
- Acquisitions, mergers or sales of businesses that could harm it.
- Loss of a key manufacturing facility in a catastrophe.
Income statement
From fiscal 2015 to 2021, earnings per share fell 31.6% a year and net income 31.1% a year, as new shares raised the share count by 2% and diluted each share's earnings. Magnera then lost money in fiscal 2022, 2023 and 2025.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY20 | FY21 | FY22 | FY23 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 100 | 138 | 111 | 50 | 305 |
| Debt incl. finance leases | 315 | 799 | 856 | 878 | 0 |
| Net debt (negative means net cash) | 216 | 660 | 745 | 828 | −305 |
| Net debt to EBITDA | 2.0x | 7.3x | — | 12.6x | −1.4x |
| Debt to equity | 0.6x | 1.5x | 2.7x | 3.4x | 0.0x |
| Interest coverage | 7.0x | 2.3x | −4.9x | 0.0x | 0.0x |
| Current ratio | 1.9x | 1.7x | 1.9x | 2.2x | 2.4x |
| Quick ratio | 1.1x | 1.0x | 1.0x | 1.1x | 1.6x |
Cash flow
Projections
Project Magnera's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
No officer, director or 10% owner of Magnera reported buying or selling its shares on the open market between November 14, 2025 and November 13, 2026.
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY22 | FY23 | FY25 |
|---|---|---|---|
| Piotroski F-score | 4 of 9 | 4 of 9 | — |
| Rule of 40 | 32.2% | −11.4% | — |
| Altman Z'' | 1.84 | 2.46 | 1.61 |
| Accruals ratio | −8.7% | −3.3% | — |
The nine F-score tests
| Test | FY22 | FY23 | FY25 |
|---|---|---|---|
| Net income is positive | Fail | Fail | — |
| Cash from operations is positive | Fail | Fail | Pass |
| Return on assets rose | Fail | Pass | — |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Fail | — |
| Current ratio rose | Pass | Pass | — |
| Share count didn't rise | Pass | Fail | — |
| Gross margin rose | Fail | Fail | — |
| Revenue rose relative to assets | Fail | Pass | — |
| F-score | 4 of 9 | 4 of 9 | — |
Compare
Put Magnera side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Magnera | FY25 | — | 0.2% | 1.1% | — | −1.4x | — | |
| Mativ | FY25 | 0.3% | −19.4% | 4.7% | −18.1% | — | 3 | Compare |
| Sonoco | FY25 | 41.7% | 13.5% | 4.6% | 9.4% | 2.6x | 5 | Compare |
| Graphic Packaging | FY25 | −2.2% | 9.3% | −0.9% | 7.3% | 4.0x | 4 | Compare |
| Avery Dennison | FY25 | 1.1% | — | 8.0% | 14.6% | 2.5x | 5 | Compare |
10 years of figures
| Fiscal year | FY15 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 1,667 | 761 | 800 | 866 | 928 | 916 | 1,085 | 1,491 | 1,386 | 3,204 |
| Revenue growth | −7.9% | −54.3% | 5.1% | 8.2% | 7.1% | −1.2% | 18.4% | 37.5% | −7.1% | — |
| Gross profit | 203 | 132 | 144 | 130 | 148 | 148 | 145 | 149 | 130 | 337 |
| Research and development | — | — | — | — | — | — | — | — | — | 20 |
| Operating income | 96 | −22 | 33 | 22 | 55 | 49 | 29 | −164 | 3 | 5 |
| Net income | 65 | 22 | 8 | −178 | −22 | 21 | 7 | −194 | −79 | −159 |
| Diluted EPS (US$) | 1.47 | 0.49 | 0.18 | −4.06 | −0.49 | 0.48 | 0.15 | −4.33 | −1.75 | −4.47 |
| Diluted shares (millions) | 44 | 44 | 44 | 44 | 44 | 45 | 45 | 45 | 45 | 36 |
| Cash flow | ||||||||||
| Cash from operations | 134 | 31 | 53 | −6 | 103 | 109 | 71 | −41 | −26 | 103 |
| Capital expenditure | 100 | 61 | 81 | 42 | 28 | 28 | 30 | 38 | 34 | 67 |
| Free cash flow | 34 | −30 | −28 | −48 | 75 | 81 | 41 | −79 | −59 | 36 |
| Dividends paid | 20 | 22 | 22 | 23 | 23 | 24 | 24 | 19 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 179 | 1 | 0 | 465 | 1 | 0 | 0 |
| Stock-based compensation | 7 | 6 | 6 | 6 | 4 | 6 | 5 | 1 | 3 | 19 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 105 | 55 | 116 | 143 | 126 | 100 | 138 | 111 | 50 | 305 |
| Debt incl. finance leases | 364 | 375 | 483 | 413 | 362 | 315 | 799 | 856 | 878 | 0 |
| Total assets | 1,500 | 1,521 | 1,731 | 1,340 | 1,284 | 1,287 | 1,881 | 1,647 | 1,564 | 3,989 |
| Total liabilities | 837 | 867 | 1,022 | 801 | 728 | 709 | 1,338 | 1,329 | 1,307 | 2,925 |
| Shareholders' equity | 663 | 654 | 709 | 539 | 556 | 578 | 543 | 318 | 257 | 1,064 |
| Margins and ratios | ||||||||||
| Gross margin | 12.2% | 17.3% | 17.9% | 15.1% | 15.9% | 16.1% | 13.3% | 10.0% | 9.4% | 10.5% |
| Operating margin | 5.8% | −2.8% | 4.2% | 2.5% | 5.9% | 5.4% | 2.6% | −11.0% | 0.2% | 0.2% |
| Net margin | 3.9% | 2.8% | 1.0% | −20.5% | −2.3% | 2.3% | 0.6% | −13.0% | −5.7% | −5.0% |
| Free cash flow margin | 2.0% | −4.0% | −3.4% | −5.5% | 8.1% | 8.8% | 3.8% | −5.3% | −4.3% | 1.1% |
| Rule of 40 (growth + FCF margin) | −5.9% | −58.3% | 1.7% | 2.7% | 15.2% | 7.6% | 22.1% | 32.2% | −11.4% | — |
| Return on capital | 8.4% | −1.8% | 1.6% | 1.2% | 5.4% | 4.0% | 1.4% | −11.4% | 0.2% | — |
| Return on equity | 9.8% | 3.3% | 1.2% | −28.5% | −3.9% | 3.8% | 1.2% | −45.1% | −27.5% | — |
| Return on assets | 4.2% | 1.4% | 0.5% | −11.6% | −1.6% | 1.7% | 0.4% | −11.0% | −4.9% | — |
| Net debt to EBITDA | 1.6x | 18.0x | 4.9x | 3.9x | 2.2x | 2.0x | 7.3x | — | 12.6x | −1.4x |